| | | 58935 | | 28.10.2008 | | Future Health Pharma GmbH | | | | | | | 27.10.2023 | | | | | | 02.07.20. | | 08.11.2023 | | 02.07.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Rasilez HCT 150mg/12.5mg | Filmtabletten | Coated tablets (Aliskirenum 150 mg, Hydrochlorothiazide 12.5 mg) | C09XA52 | CI | | 02 | Rasilez HCT 150mg/25mg | Filmtabletten | Coated tablets (Aliskirenum 150 mg, Hydrochlorothiazide 25 mg) | C09XA52 | CI | | 03 | Rasilez HCT 300mg/12.5mg | Filmtabletten | Coated tablets (Aliskirenum 300 mg, Hydrochlorothiazide 12.5 mg) | C09XA52 | CI | | 04 | Rasilez HCT 300mg/25mg | Filmtabletten | Coated tablets (Aliskirenum 300 mg, Hydrochlorothiazide 25 mg) | C09XA52 | CI |
|
|
